| International Journal of Clinical Pediatrics, ISSN 1927-1255 print, 1927-1263 online, Open Access |
| Article copyright, the authors; Journal compilation copyright, Int J Clin Pediatr and Elmer Press Inc |
| Journal website http://www.theijcp.org |
Case Report
Volume 9, Number 1, March 2020, pages 24-29
Bone Marrow Necrosis in a Child With Sepsis-Induced Macrophage Activation Syndrome
Figure

Tables
| Investigations | At admission | Day 3 | Day 7 | Day 10 |
|---|---|---|---|---|
| PT: prothrombin time; INR: international normalized ratio; aPTT: activated partial thromboplastin time; CRP: C-reactive protein. | ||||
| Complete blood counts | ||||
| Hemoglobin (g/L) | 74 | 108 | 95 | 61 |
| Total leukocyte count (× 109/L) | 1,700 | 2,110 | 2,490 | 28,840 |
| Neutrophils (%) | - | 7.6 | 2.9 | 84.7 |
| Lymphocytes (%) | - | 87.2 | 93.4 | 11.4 |
| Monocytes (%) | - | 5.2 | - | 3.7 |
| Eosinophils (%) | - | - | 0.8 | - |
| Basophils (%) | - | - | - | - |
| Platelets (× 109/L) | 38,000 | 4,000 | 28,000 | 53,000 |
| Renal function test | ||||
| Urea (mg/dL) | 65 | 108 | 96 | 107 |
| Creatinine (mg/dL) | 0.7 | 0.73 | 0.5 | 0.54 |
| Coagulogram | ||||
| PT (seconds) | 21 | 17 | 14.8 | |
| PTI (%) | 62 | 66 | 76 | |
| INR | 2.53 | 1.53 | 1.33 | |
| aPTT (s) | 37 | |||
| D-dimer (ng/mL) | 5090 | 4741 | ||
| MAS parameters | ||||
| Ferritin (ng/mL) | 2,623 | 3,245 | ||
| Fibrinogen (g/L) | 5.72 | 3.41 | ||
| Triglycerides (mg/dL) | 266 | 156 | ||
| Inflammatory parameters | ||||
| CRP (mg/L) | 195.7 | 194 | 173 | |
| Procalcitonin (ng/mL) | 49.48 | 32.49 | ||
| Microbiological investigations | ||||
| Blood culture | Day 1: methicillin-resistant Staphylococcus aureus | |||
| Day 6: Escherichia coli | ||||
| Day 8: Candida tropicalis | ||||
| Pus culture | Day 2: methicillin-resistant Staphylococcus aureus | |||
| Kinney et al [5] | Terheggen et al [6] | Garewal et al [7] | Garewal et al [7] | Index case | |
|---|---|---|---|---|---|
| HSM: hepatosplenomegaly; MRSA: methicillin-resistant Staphylococcus aureus; IVIG: intravenous immunoglobulin; TRALI: transfusion-related acute lung injury. | |||||
| Year of reporting | 1977 | 1979 | 1991 | 1991 | 2020 |
| Age (years) | 15 | 8 | 2.5 | 3.5 | 10 |
| Sex | Female | Male | Male | Male | Female |
| Clinical presentation | Migratory arthralgia, epistaxis, weight loss, polyarthritis, fever, hepatomegaly | Fever, furuncle, joint and limb pain, HSM | Pallor, mucocutaneous gangrene, popliteal ulcer, HSM | Fever, epistaxis, oral ulcer, pallor, pneumonia, HSM | Fever, erythematous rash, epistaxis, pneumonia, chest wall abscess, hepatomegaly, shock |
| Hemoglobin (g/dL) | 5.6 | 12 | 4.3 | 5.2 | 7.4 |
| Total leukocyte count (× 109/L) | 7.05 | 2.5 | 2.0 | 1.6 | 1.7 |
| Absolute neutrophil count (× 109/L) | 3.9 | - | 0.8 | 0.2 | 0.6 |
| Platelet count (× 109/L) | 86 | 78 | 10 | 10 | 31 |
| Blood culture | Staphylococcus aureus | Group A Streptococcus | Pseudomonas aeruginosa | Salmonella typhimurium | MRSA |
| Features suggestive of macrophage activation syndrome | Fever, hepatomegaly, anemia, thrombocytopenia | Fever, HSM, thrombocytopenia, leukopenia | HSM, pancytopenia | Fever, HSM, pancytopenia | Fever, hepatomegaly, pancytopenia, hyperferritinemia, hypertriglyceridemia |
| Treatment | Antibiotics and prednisolone | Antibiotics | Antibiotics | Antibiotics | Antibiotics, IVIG, methylprednisolone pulse |
| Outcome | Improved, developed breast lymphosarcoma after 11 months and ultimately died of it. | Discharged on day 13, no long-term follow-up | Discharged on day 12, no long-term follow-up. | Developed septic arthritis and skin abscesses, and died. | Initially shown improvement, died on day 12 due to TRALI. |